Pharmaceutical enterprises operate complex environments supporting research, manufacturing, clinical operations, regulated data, supply chain, laboratory systems, cloud platforms, endpoints, applications, and infrastructure. Vulnerability management in this environment is not just about scanning systems. The real challenge is turning findings into prioritized, actionable remediation.

A pharmaceutical enterprise engaged our team to build a Continuous Vulnerability Program that reduced critical vulnerabilities by 92% within 90 days and maintained a sub-72-hour remediation SLA for high-severity findings.

The Problem

The organization had scanning tools in place, but the program was not continuous. Reports were distributed manually, duplicate findings created noise, asset ownership was unclear, and infrastructure teams did not always receive practical remediation guidance.

Key challenges included incomplete scan coverage, large volumes of findings, difficulty prioritizing business-critical risks, manual reporting, delayed patching, unclear ownership, limited post-remediation validation, and lack of live dashboards for security, infrastructure, application, and compliance teams.

Infrastructure teams often received CVE lists without enough context to fix them quickly. They needed to know which systems were affected, what patch was required, whether a reboot was needed, what business service was impacted, and how remediation would be validated.

The Assessment

We began with a vulnerability management maturity assessment covering internal scanning, external attack surface scanning, cloud workloads, endpoints, servers, authenticated scan coverage, patch workflows, ticketing, remediation SLAs, and reporting.

AI-assisted analytics normalized vulnerability data from multiple tools and grouped findings by asset, owner, technology stack, exploitability, business criticality, internet exposure, and remediation path.

The assessment showed that the organization needed more than scanning. It needed a continuous, risk-based operating model.

The Solution

We designed a Continuous Vulnerability Program built on five capabilities: visibility, prioritization, actionable remediation, validation, and reporting.

Scanning was expanded across data center servers, cloud workloads, Windows and Linux systems, databases, web applications, internet-facing assets, endpoints, network devices, container images, and critical business applications. Authenticated scanning improved accuracy, while agent-based scanning supported remote systems that were not always reachable.

Assets were grouped by business unit, application owner, infrastructure team, criticality, environment type, regulatory relevance, internet exposure, and patch window.

AI-Assisted Prioritization

AI helped prioritize findings based on real-world risk, not severity alone. The model considered CVSS severity, known exploitation, exploit likelihood, internet exposure, asset criticality, data sensitivity, business function, patch availability, vulnerability age, compensating controls, and whether the system supported regulated or validated processes.

Findings were grouped into practical tiers: emergency, critical, high, standard, and exception. This gave remediation teams a clear order of operations.

Contextual Remediation

One of the biggest improvements was how remediation guidance was delivered. Instead of sending generic reports, we created actionable remediation tickets for each support team.

Each ticket included affected asset, business owner, vulnerability title, CVE, severity, reason for priority, known exploitation status, required patch or configuration change, vendor guidance, reboot requirement, suggested maintenance window, due date, validation method, and exception options.

This helped infrastructure and application teams fix issues faster with less back-and-forth.

Continuous Validation and Dashboards

The program included scheduled authenticated scans, agent-based updates, external attack surface testing, cloud monitoring, post-remediation validation, reopened ticket detection, patch verification, exception review, and compensating control validation.

Live dashboards were created for different audiences. Executives saw risk reduction, critical vulnerability trends, SLA performance, and business unit exposure. Infrastructure teams saw open vulnerabilities, patch status, reboot requirements, failed validations, and upcoming due dates. Application owners saw vulnerabilities by application and remediation owner. Compliance teams saw SLA evidence, exceptions, remediation history, and regulated system exposure.

Outcomes

Within 90 days, the enterprise achieved measurable improvement:

  • Critical vulnerabilities reduced by 92%
  • Sub-72-hour SLA maintained for high-severity findings
  • Improved coverage across infrastructure, cloud, endpoints, and applications
  • Vulnerability ownership mapped to correct teams
  • Duplicate findings reduced through normalization
  • Remediation tickets enriched with clear technical guidance
  • Post-remediation validation automated
  • Live dashboards created for all stakeholder groups
  • Manual reporting effort reduced
  • Better exception and risk acceptance governance

How We Help

Our team helps pharmaceutical and life sciences organizations build continuous vulnerability programs. Services include scanner deployment, internal and external scanning, cloud vulnerability management, risk-based prioritization, AI-assisted remediation guidance, ticketing integration, validation, dashboards, SLA tracking, exception governance, and managed vulnerability support.

Contact us today to schedule a Continuous Vulnerability Program Assessment and learn how we can help reduce vulnerability risk and improve remediation performance.